Drug · DIN 02298791
EMEND
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 24, 2007; first marketed September 24, 2007.
- Drug Identification Number (DIN)
- 02298791
- Company (DIN owner)
- Merck Canada IncKirkland, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Aprepitant A04AD12
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| APREPITANT | 80 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 24, 2007: NOC 8991New Drug Submission (NDS)
Other DINs named EMEND
- DIN 02298805 · Marketed